Drug Safety: Improvement Needed in FDA’s Postmarke

Home > Diane Publishing Books >

Drug Safety: Improvement Needed in FDA’s Postmarket Decision-Making and Oversight Process

Our Price: $20.00

By Marcia Crosse (au)
Year: 2006
Pages: 62
Binding Paperback

Product Code: 1422307018

Description

In 2004, several high-profile drug safety cases raised concerns about the Food & Drug Admin.’s (FDA) ability to manage postmarket drug safety issues. In some cases there have been disagreements within FDA about how to address safety issues. This report: (1) describes FDA’s organizational structure & process for postmarket drug safety decision making; (2) assesses the effectiveness of FDA’s postmarket drug safety decision-making process; & (3) assesses the steps FDA is taking to improve postmarket drug safety decision making. An organizational review was conducted. In addition, there are case studies of 4 drugs with safety issues: Arava, Baycol, Bextra, & Propulsid. Includes recommendations. Illustrations.

Share your knowledge of this product with other customers... Be the first to write a review